🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsHas anyone dealt with compounded sema dosing calculator? Page 2

Has anyone dealt with compounded sema dosing calculator?

AttorneyGrant Wed, Sep 10, 2025 at 10:50 AM 26 replies 1,412 viewsPage 2 of 6
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Sep 10, 2025 at 4:26 PM#6
AttorneyGrant said:
The shortage clause is the answer to the second question and it is a subtraction rather than an addition.

I have been on both brand and compounded, and in the context of compounded supply, my experience has been equivalent with both. The key is finding a reliable 503B pharmacy with independent testing.

2 22ingrid_STO, pete_nash
Reply Quote Save Share Report
RickReta_CO
Member
312
1,234
Jan 2025
Colorado
Sep 10, 2025 at 6:38 PM#7

A narrower follow-up, since the general answer is now clear:

Why a shortage listing created a legal pathway at all, since a shortage is a supply fact rather than a permission?

1 21jim_asheville
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Sep 10, 2025 at 8:50 PM#8
hank_denver said:
I have been on both brand and compounded, and in the context of compounded supply, my experience has been equivalent with both.

503A vs 503B compounding pharmacies for compounded supply — this distinction matters enormously:

Feature503A503B
RegulationState Board of PharmacyFDA-registered
PrescriptionRequired (patient-specific)Can compound without patient Rx
TestingVaries by statecGMP required
ScaleSmall batchesLarger production
Quality consistencyVariableGenerally higher

I strongly recommend 503B facilities. The FDA oversight and cGMP requirements mean more consistent product quality.

50 20FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 47 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
Sep 10, 2025 at 11:02 PM#9

Closing the loop on my own question.

The bulks-list asymmetry was the piece I had missed entirely. It explains why one of my two pharmacies is still arguing it can supply and the other simply stopped.

49 19pat_auckland, Dr.GastroMayo, JakeBK_lifts and 46 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Sep 11, 2025 at 9:33 AM#10
PeptideChemSF said:
503A vs 503B compounding pharmacies for compounded supply — this distinction matters enormously: Feature 503A 503B Regulation State Board of Pharmacy…

PeptideChemSF has the substance of this right. The condition it depends on is worth stating. Worth adding the genuine exception, because it is real and narrow: a change made for an identified patient where the prescriber determines it produces a significant clinical difference for that patient. A grid of fixed doses offered to everybody is not that, whatever the intake form says.

17 17RickReta_CO, PharmHunterJen, TomTeleRx and 14 others
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register